Matrix metalloproteinases in cancer invasion, metastasis and angiogenesisFODA, Hussein D; ZUCKER, Stanley.Drug discovery today. 2001, Vol 6, Num 9, pp 478-482, issn 1359-6446Article

Role of matrix metalloproteinases (MMPs) in colorectal cancerZUCKER, Stanley; VACIRCA, Jeffrey.Cancer metastasis reviews. 2004, Vol 23, Num 1-2, pp 101-117, issn 0167-7659, 17 p.Article

Roles of the multifunctional glycoprotein, emmprin (basigin; CDI47), in tumour progression : Proteases and extracellular environmentLI YAN; ZUCKER, Stanley; TOOLE, Bryan P et al.Thrombosis and haemostasis. 2005, Vol 93, Num 2, pp 199-204, issn 0340-6245, 6 p.Article

Matrix metalloproteinase inhibitors (MMPIs): The beginning of phase I or the termination of phase III clinical trialsPAVLAKI, Maria; ZUCKER, Stanley.Cancer metastasis reviews. 2003, Vol 22, Num 2-3, pp 177-203, issn 0167-7659, 27 p.Article

The organomercurial 4-aminophenylmercuric acetate, independent of matrix metalloproteinases, induces dose-dependent activation/inhibition of platelet aggregationROSENFELDT, Mathias T; VALENTINO, Michael; LABRUZZO, Salvatore et al.Thrombosis and haemostasis. 2005, Vol 93, Num 2, pp 326-330, issn 0340-6245, 5 p.Article

Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan productionMARIEB, Erica A; ZOLTAN-JONES, Alexandra; RONGSONG LI et al.Cancer research (Baltimore). 2004, Vol 64, Num 4, pp 1229-1232, issn 0008-5472, 4 p.Article

Mechanical stretch induces MMP-2 release and activation in lung endothelium: role of EMMPRINHASENEEN, Nadia A; VADAY, Gayle G; ZUCKER, Stanley et al.American journal of physiology. Lung cellular and molecular physiology. 2003, Vol 28, Num 3, pp L541-L547, issn 1040-0605Article

Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic strokeKAPLAN, Robert C; SMITH, Nicholas L; ZUCKER, Stanley et al.Atherosclerosis. 2008, Vol 201, Num 1, pp 130-137, issn 0021-9150, 8 p.Article

Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furinLOPEZ DE CICCO, Ricardo; BASSI, Daniel E; ZUCKER, Stanley et al.Cancer research (Baltimore). 2005, Vol 65, Num 10, pp 4162-4171, issn 0008-5472, 10 p.Article

Rapid trafficking of membrane type 1-matrix metalloproteinase to the cell surface regulates progelatinase A activationZUCKER, Stanley; HYMOWITZ, Michelle; CONNER, Cathleen E et al.Laboratory investigation. 2002, Vol 82, Num 12, pp 1673-1684, issn 0023-6837, 12 p.Article

Tumorigenic potential of extracellular matrix metalloproteinase inducerZUCKER, Stanley; HYMOWITZ, Michelle; ROLLO, Ellen E et al.The American journal of pathology. 2001, Vol 158, Num 6, pp 1921-1928, issn 0002-9440Article

Unraveling the Role of KIAA1199, a Novel Endoplasmic Reticulum Protein, in Cancer Cell MigrationEVENSEN, Nikki A; KUSCU, Cem; JIAN CAO et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 18, pp 1402-1416, issn 0027-8874, 15 p.Article

Small-Molecule Anticancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9DUFOUR, Antoine; SAMPSON, Nicole S; JIAN CAO et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 14, pp 4977-4988, issn 0008-5472, 12 p.Article

CXCR4 and CXCL12 (SDF-1) in prostate cancer: Inhibitory effects of human single chain Fv antibodiesVADAY, Gayle G; HUA, Shao-Bing; PEEHL, Donna M et al.Clinical cancer research. 2004, Vol 10, Num 16, pp 5630-5639, issn 1078-0432, 10 p.Article

Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group Trial E2196SPARANO, Joseph A; BERNARDO, Patricia; STEPHENSON, Patricia et al.Journal of clinical oncology. 2004, Vol 22, Num 23, pp 4631-4638, issn 0732-183X, 8 p.Article